Clinical trial

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

NCT02203695

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-03-28

PhasePHASE2

Study timeline

Study start (actual)2015-03-28Date precision: day

Registry last updated2025-10-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adenocarcinoma of the Prostateunresolved

Interventions

EnzalutamideDRUG · verified · RxNorm: enzalutamide

SRTRADIATION

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinslead sponsor

Astellas Pharma Inccollaborator

Medivation, Inc.collaborator

Mapped research locations

ChicagoIllinois, United States1 BaltimoreMaryland, United States1 PortlandOregon, United States1 Washington D.C.District of Columbia, United States1 DetroitMichigan, United States1 Ann ArborMichigan, United States1 Salt Lake CityUtah, United States1 BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02203695 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.